{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:16:10Z","timestamp":1761884170631,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.reumae.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:10:26Z","timestamp":1683828626000},"page":"338-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report"],"prefix":"10.1016","volume":"19","author":[{"given":"Paira","family":"Sergio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reibaldi","family":"Alejandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Froullet","family":"Cristian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2023.05.001_bib0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1590\/0004-282x20200073","article-title":"A clinical approach to hypertrophic pachymeningitis","volume":"78","author":"Abrantes","year":"2020","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.reumae.2023.05.001_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-Related Disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reumae.2023.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archneur.58.8.1215","article-title":"Standardizaed neurologic evaluations of 128 patients with granulomatosis","volume":"58","author":"Groot","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0020","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00415-017-8416-0","article-title":"Characteristics of pachymeningitis hypertrophic in patients with granulomatosis with polyangeitis","volume":"264","author":"Choi","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ccr3.1418","article-title":"Not everything is as is seems: neurosarcoidosis presenteing as leptomeningitis","volume":"6","author":"Galnare-Olalde","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.reumae.2023.05.001_bib0030","article-title":"Tuberculous pachymeningitis presenting as a diffused dural thikening in patient with chronic headache and recurrent neurological abdnormalities for more than a decade: a case report and a review of litheratura","volume":"2018","author":"Fonseka","year":"2018","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.reumae.2023.05.001_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","article-title":"Rosai-Dorfman disease: an overview","volume":"73","author":"Bruce-Brand","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0040","first-page":"96","article-title":"Emperipolesis en sindromes mielodiplasicos","volume":"23","author":"Rodr\u00edguez","year":"2019","journal-title":"Hematolog\u00eda"},{"key":"10.1016\/j.reumae.2023.05.001_bib0045","first-page":"205","article-title":"Adenopatias cervicales en reumatologia: un dilema diagnostico","author":"Sager","year":"2022","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/modpathol.3880278","article-title":"Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases","volume":"14","author":"Andriko","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflamatory myofibroblastic tumor (inflamatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0b013e3181a5a207","article-title":"Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor. A comparative clinicopathologic study","volume":"33","author":"Yamamoto","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0065","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/art.40168","article-title":"IgG4-Related Disease: insights into human inmunology and targeted therapies","volume":"69","author":"Perugino","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0070","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-Related Disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2023.05.001_bib0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/jclinpath-2012-200749","article-title":"Isolated cutaneous manifestation of IgG4-Related Disease","volume":"65","author":"Hattori","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/357071","article-title":"Are classification criteria for IgG4-RD now possible? The concept of IgG4-Related Disease and proposal of comprehensive diagnostic criteria in Japan","volume":"2012","author":"Okazaki","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0085","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-Related Disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0090","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of inmunoglubulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2023.05.001_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"Mechanisms of disease IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2023.05.001_bib0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.reuma.2016.05.009","article-title":"Enfermedad relacionada con IgG4: revisi\u00f3n concisa de la literatura","volume":"13","author":"Ardila-Suarez","year":"2017","journal-title":"Reumatol Clin"},{"issue":"Suppl: 1","key":"10.1016\/j.reumae.2023.05.001_bib0110","first-page":"S1","article-title":"Paquimeningitis hipertr\u00f3fica relacionada con IgC4: comunicaci\u00f3n de otros 11 casos y revisi\u00f3n de la literatura","volume":"21","author":"Roverano","year":"2019","journal-title":"Rev Cub de Reu."},{"key":"10.1016\/j.reumae.2023.05.001_bib0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Desphande","year":"2012","journal-title":"Modern Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League against Rheumatism classification criteria of IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: clinico-pathological featuresf and proposal for diagnostic criteria","volume":"120","author":"Lindstrom","year":"2010","journal-title":"Acta neuropathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/580814","article-title":"Cutoof values of serum IgG4 and Histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease","volume":"2012","author":"Masaki","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.10.008","article-title":"Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis","volume":"266","author":"Della-Torre","year":"2014","journal-title":"J Neuroinmmunol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-156-5-201203060-00025","article-title":"IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis","volume":"156","author":"Della-Torre","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reumae.2023.05.001_bib0160","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3899\/jrheum.130678","article-title":"Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis","volume":"40","author":"Della-Torre","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0165","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/1756-185X.12739","article-title":"Alteration of IgG4 levels in cerebrospinal fluid in IgG4-related disease","volume":"20","author":"Fernandez-Codina","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2023.05.001_bib0170","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-Related Disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2023.05.001_bib0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/RLU.0b013e31823933c1","article-title":"Hypertrophic cranial pachymeningitis with IgG4-positive plasma cells detected by C-11 methionine PET","volume":"37","author":"Norikane","year":"2012","journal-title":"Clin Nucl Med"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:03:14Z","timestamp":1761879794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574323000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2173574323000904"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2023.05.001","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2022.11.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}